Julian Hess

Julian Hess

Harvard University

H-index: 22

North America-United States

About Julian Hess

Julian Hess, With an exceptional h-index of 22 and a recent h-index of 22 (since 2020), a distinguished researcher at Harvard University, specializes in the field of Cancer Genomics.

His recent articles reflect a diverse array of research interests and contributions to the field:

Combined PD-1, BRAF and MEK inhibition in BRAFV600E colorectal cancer: a phase 2 trial

Evolutionary history of transformation from chronic lymphocytic leukemia to Richter syndrome

The Four mRNA Bases Have Quite Different (Un) folding Free Energies, Applications to RNA Splicing and Translation Initiation with BindOligoNet

Cas9 activates the p53 pathway and selects for p53-inactivating mutations

Analyses of non-coding somatic drivers in 2,658 cancer whole genomes

Julian Hess Information

University

Position

Broad Institute of MIT and Harvard

Citations(all)

15820

Citations(since 2020)

13855

Cited By

7498

hIndex(all)

22

hIndex(since 2020)

22

i10Index(all)

22

i10Index(since 2020)

22

Email

University Profile Page

Google Scholar

Julian Hess Skills & Research Interests

Cancer Genomics

Top articles of Julian Hess

Combined PD-1, BRAF and MEK inhibition in BRAFV600E colorectal cancer: a phase 2 trial

Nature Medicine

2023/2

The Four mRNA Bases Have Quite Different (Un) folding Free Energies, Applications to RNA Splicing and Translation Initiation with BindOligoNet

Journal of Molecular Biology

2022/6/15

Cas9 activates the p53 pathway and selects for p53-inactivating mutations

Nature genetics

2020/7/2

See List of Professors in Julian Hess University(Harvard University)